Target intelligence / Profile preview

RNA, U1 small nuclear 29, pseudogene (RNU1-29P)

Target
RNU1-29P
Molecular classification
Other (non-coding RNA pseudogene), Small nuclear RNA (snRNA) pseudogene, Non-protein-coding gene
01

Overview

RNA, U1 small nuclear 29, pseudogene (RNU1-29P) is a human gene encoded as a **pseudogene** for U1 small nuclear RNA, a component involved in the spliceosome machinery for pre-mRNA splicing[1][2][3][4]. The canonical U1 snRNA plays a key role in recognizing the 5’ splice site during RNA splicing, but RNU1-29P itself is generally considered a non-functional pseudogene sequence that does not encode a functional RNA or protein product[1][2][3][4]. However, there is emerging evidence that some U1 snRNA pseudogenes—previously considered non-functional—may generate processed transcripts that regulate gene expression at the RNA level in certain contexts, possibly by acting as RNA decoys or modulators of RNA processing[2]. For RNU1-29P specifically, there is **no direct evidence** of functionality and it is not considered a therapeutic target, receptor, enzyme, transporter, or functional gene product[1][2][3][4]. Its main relevance is as a **genomic locus classified as a non-coding RNA pseudogene**.

Other names
RNU1-29PRNA, U1 small nuclear 29 pseudogene
02

Biological functions

Possible regulation of gene expression at the RNA level (as for other U1 snRNA pseudogenes, see [2])Putative function in nuclear ribonucleoprotein complexes (RNPs) if transcribed, though direct evidence for RNU1-29P itself is lacking[2][3]
03

Disease associations

Other (no established disease relevance; possible roles for variant U1 snRNA pseudogenes in regulation, but not specifically for RNU1-29P)[2]

Beyond the preview

Go deeper on RNA, U1 small nuclear 29, pseudogene (RNU1-29P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U1 small nuclear 29, pseudogene (RNU1-29P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call